BloodTrackR Usability and Concordance in RA
Official title: BloodTrackR Usability and Concordance Study (BUCS)
Run by University of Ulster · NCT07660029 · Data updated 2026-11-12
This study tests a home blood collection device and accompanying app for people with rheumatoid arthritis to see if they can collect usable samples at home and whether the results match standard blood tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Ulster Academic / other |
| Locations | 1 site (Londonderry) |
| Status | Recruiting |
| Started | June 2026 |
| Main results expected | September 2026 |
| Study ends | December 2026 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT07660029 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with rheumatoid arthritis who can understand English, own a smartphone/tablet with WiFi, and can consent to participate.
✕Probably not a fit
Individuals unable to perform self-collection or lacking reliable internet or device access may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates a home-based finger-prick blood collection device (BloodTrackR) and a companion mobile app in adults with rheumatoid arthritis. Participants will collect samples at home and complete symptom assessments via the app to assess usability, sample quality, and concordance with venous blood tests performed by a phlebotomist. The goal is to determine whether remote, patient-led blood testing can support real-time monitoring and potentially reduce the need for NHS phlebotomy visits. The study addresses practical barriers to community-based blood testing and the accuracy limitations of alternative methods like dried blood spots. Findings will inform the feasibility of remote monitoring for inflammatory markers and disease activity in RA, with implications for patient experience and healthcare resource use.
Why it matters
Potential benefit: If successful, patients could benefit from easier access to monitoring and faster insight into disease activity without frequent clinic visits.
How similar studies have gone: Prior research in remote self-collection shows promise for accuracy, but findings vary by device and analyte; this study contributes RA-specific usability and concordance data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals living with rheumatoid arthritis, who attend community groups or rheumatoid arthritis charity groups * Aged 18 years or older * Able to understand written and spoken English * Individuals who have the capacity to consent * Access to WiFi and a smartphone/tablet Exclusion Criteria: * Participants \<18years * Participants taking antibiotics/antivirals * No access to WiFi or a smartphone/tablet
Where it's running
-
Personalised Medicine Centre
Londonderry, United Kingdom Recruiting
Study contacts
- Principal investigator: David Gibson — Ulster University
- Study coordinator: Jency Rajan
- Email: j.rajan@ulster.ac.uk
- Phone: 00447486455613
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart Rate Variability and Rheumatoid Arthritis: What HRV Looks Like with RA
This study checks whether continuous HRV data from an Oura ring can reflect RA disease activity in adults with RA.
-
Discontinuing MTX or LEF in RA Patients on TNF Inhibitors
This trial tests whether stopping methotrexate or leflunomide while continuing a TNF inhibitor is not worse for disease control in adults with rheumatoid arthritis.
-
FT839 therapy for autoimmune diseases
This trial tests FT839, given alone or with rituximab, to see if it is safe and can help people with certain autoimmune diseases who have not responded to other treatments.
-
24-Hour Movement and Atherosclerotic Risk in adults with rheumatoid arthritis
This study tests how daily activity, sitting, and sleep relate to heart-related risk in adults with RA, using wearables and follow-up after a year.
-
Integrative AI profiling of chronic RA pain
This study tests whether an AI-driven multiomic and neurophysiological approach can help explain and predict persistent pain in adults with active rheumatoid arthritis.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.